CA Patent

CA2862038C — Peptidomimetic macrocycles

Assigned to Rein Therapeutics Inc · Expires 2021-05-25 · 5y expired

What this patent protects

Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.

USPTO Abstract

Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.

Drugs covered by this patent

pasireotide-pamoate (PASIREOTIDE PAMOATE)

Patent Metadata

Patent number: CA2862038C
Jurisdiction: CA
Classification: —
Expires: 2021-05-25
Drug substance claim: No
Drug product claim: No
Assignee: Rein Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.